Jitendra Kumar¹*, Pankaj Goel², Vineeta Yadav³ and Arif Merchant⁴

¹Resident Doctor, Department of Dentistry, Saket Nagar, AIIMS Bhopal, Madhya Pradesh, India
²Professor and HOD, Department of Dentistry, Saket Nagar, AIIMS Bhopal, Madhya Pradesh, India
³Senior Resident, Department of Dentistry, Govt. Medical College, Gondia, Maharashtra, India
⁴Consultant Maxillofacial Surgeon, Dhule, Maharashtra, India

*Corresponding Author: Jitendra Kumar, Resident Doctor, Department of Dentistry, Saket Nagar, AIIMS Bhopal, Madhya Pradesh, India.

Received: December 17, 2021; Published: January 18, 2022

Abstract

The choice of treatment related to Oral Submucous Fibrosis is still controversial and depends on the stage of the clinical and histological finding.

A 25-year male patient was diagnosed with Oral Sub Mucous Fibrosis with the help of histological and clinical finding. The mouth opening of the patient was less than 5mm. A surgical treatment was planned for the patient by excision of the lesion followed by placement of graft from the abdomen.

The report highlights the disability limitation and treatment plan in severe case of Oral Sub Mucous Fibrosis.

Keywords: Oral Submucous Fibrosis; Oral Cancer; Tertiary Prevention; Disability Limitation

References

1. Shih YH., et al. “Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy”. International Journal of Molecular Sciences 12 (2019): 2940.
2. Liu D., et al. “A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy”. Allergy, Asthma and Clinical Immunology 9 (2013): 30.
3. Tsai CC., et al. “Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis”. Journal of Oral Pathology and Medicine 28 (1999): 59-63.
4. Arakeri G., et al. “Oral submucous fibrosis: An update on current theories of pathogenesis”. Journal of Oral Pathology and Medicine 46 (2017): 406-412.
5. More C., et al. “Classification system of Oral submucous fibrosis”. Journal of Indian Academy of Oral Medicine and Radiology 1 (2012): 24-29.
6. https://www.care-statement.org/
7. Rajendran R., et al. “Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis”. Indian Journal of Dental Research 4 (2006): 190-198.
8. Chan SS., et al. “Mechanisms underlying the vasorelaxing effects of butylidenephthalide, an active constituent of Ligusticum chuanxiong, in rat isolated aorta”. European Journal of Pharmacology 537 (2006): 111-117.
9. Hsieh YP., et al. “Arecoline stimulated early growth response-1 production in human buccal fibroblasts: Suppression by epigallocatechin-3-gallate”. Head and Neck 37 (2015): 493-497.
10. Khanna JN and Andrade NN. “Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases”. International Journal of Oral and Maxillofacial Surgery 24 (1995): 433-439.
11. Lee J-T., et al. “A double-skin paddle radial forearm flap for the reconstruction of oral submucous fibrosis”. Tzu Chi Medical Journal 18 (2006): 362-369.
12. Morawetz G., et al. “Oral submucous fibrosis”. International Journal of Oral and Maxillofacial Surgery 16 (1987): 609-614.

Citation

Citation: Jitendra Kumar., et al. “Excision of Oral Submucous Fibrosis and Reconstruction with Full Thickness Skin Graft: A Case Report and Review of Various Treatment Modalities”. Acta Scientific Dental Sciences 6.2 (2022): 78-81.

Copyright

Copyright: © 2022 Jitendra Kumar., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.